Antiviral Therapy and Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence

被引：0
|
作者：
Yeh, Yi-Chun [1 ]
Chen, Pei-Jer [2 ]
Lai, Mei-Shu [1 ]
机构：
[1] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan
[2] Natl Taiwan Univ & Hosp, Hepatitis Res Ctr, Taipei, Taiwan
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2013年 / 309卷 / 08期
关键词：
IMMORTAL TIME BIAS;
D O I：
10.1001/jama.2013.571
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：765 / 766
页数：2
相关论文
共 50 条
  • [31] Postoperative antiviral therapy with nucleos(t)ide analogs for patients with hepatitis B virus-related hepatocellular carcinoma
    Jiang, Jing-Hang
    Zhong, Jian-Hong
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (03) : E29 - E30
  • [32] Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma:A meta-analysis
    Ruo-Yu Miao
    World Journal of Gastroenterology, 2010, 16 (23) : 2931 - 2942
  • [33] Preoperative antiviral therapy and microvascular invasion in hepatitis B virus-related hepatocellular carcinoma: A meta-analysis
    Wang, Zhenchang
    Duan, Yunjie
    Zhang, Jinmei
    Lv, Yanhang
    Wu, Shanshan
    Cheng, Mingrong
    Bhagavathula, Akshaya Srikanth
    Aldhaleei, Wafa Ali
    Clark, Cain
    Huo, Zongwei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 883
  • [34] Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: A meta-analysis
    Miao, Ruo-Yu
    Zhao, Hai-Tao
    Yang, Hua-Yu
    Mao, Yi-Lei
    Lu, Xin
    Zhao, Yi
    Liu, Chang-Ning
    Zhong, Shou-Xian
    Sang, Xin-Ting
    Huang, Jie-Fu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (23) : 2931 - 2942
  • [35] Review Article Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
    Kim, Beom Kyung
    Ahn, Sang Hoon
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (12) : 1238 - 1246
  • [36] Comparative efficacy of postoperative transarterial chemoembolization with or without antiviral therapy for hepatitis B virus-related hepatocellular carcinoma
    Zhu, Shao-Liang
    Zhong, Jian-Hong
    Ke, Yang
    Xiao, Hui-Min
    Ma, Liang
    Chen, Jie
    You, Xue-Mei
    Li, Le-Qun
    TUMOR BIOLOGY, 2015, 36 (08) : 6277 - 6284
  • [37] Prediction model of hepatocellular carcinoma in patients with hepatitis B virus-related compensated cirrhosis receiving antiviral therapy
    Wang, Hung -Wei
    Chen, Chi-Yi
    Lai, Hsueh-Chou
    Hu, Tsung-Hui
    Su, Wen-Pang
    Lu, Sheng-Nan
    Hung, Chao-Hung
    Chuang, Po-Heng
    Wang, Jing-Houng
    Chen, Chien -Hung
    Peng, Cheng-Yuan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (02): : 526 - +
  • [38] Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
    Peng Wang
    Xinhui Wang
    Xiaoli Liu
    Fengna Yan
    Huiwen Yan
    Dongdong Zhou
    Lihua Yu
    Xianbo Wang
    Zhiyun Yang
    BMC Cancer, 23
  • [39] Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy
    Chang, Kai-Chun
    Su, Tung-Hung
    Liao, Sih-Han
    Tseng, Tai-Chung
    Huang, Shang-Chin
    Hsu, Shih-Jer
    Hong, Chun-Ming
    Liu, Chen-Hua
    Yang, Hung-Chih
    Liu, Chun-Jen
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (08) : 891 - 898
  • [40] Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma
    Toru Ishikawa
    World Journal of Gastroenterology, 2013, (47) : 8861 - 8866
12345